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Abstract
Multiple sclerosis (MS) is a complex demyelinating disease of the central nervous system. Current research has shown that at
least in some cases, the primary insult in MS could be directed at the oligodendrocyte, and that the earliest immune
responses are primarily via innate immune cells. We have identified a family of receptor protein tyrosine kinases, known as
the TAM receptors (Tyro3, Axl and Mertk), as potentially important in regulating both the oligodendrocyte and immune
responses. We have previously shown that Gas6, a ligand for the TAM receptors, can affect the severity of demyelination in
mice, with a loss of signalling via Gas6 leading to decreased oligodendrocyte survival and increased microglial activation
during cuprizone-induced demyelination. We hypothesised TAM receptor signalling would also influence the extent of
recovery in mice following demyelination. A significant effect of the absence of Gas6 was detected upon remyelination, with
a lower level of myelination after 4 weeks of recovery in comparison with wild-type mice. The delay in remyelination was
accompanied by a reduction in oligodendrocyte numbers. To understand the molecular mechanisms that drive the
observed effects, we also examined the effect of exogenous Gas6 in in vitro myelination assays. We found that Gas6
significantly increased myelination in a dose-dependent manner, suggesting that TAM receptor signalling could be directly
involved in myelination by oligodendrocytes. The reduced rate of remyelination in the absence of Gas6 could thus result
from a lack of Gas6 at a critical time during myelin production after injury. These findings establish Gas6 as an important
regulator of both CNS demyelination and remyelination.
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Introduction
Multiple Sclerosis (MS) is a complex demyelinating disease of
the central nervous system (CNS). Although the initiating insult in
MS remains unknown, it is clear that the pathology of MS involves
complex interactions between many systems and cell types,
including neurons, glia and both the innate and adaptive immune
systems.
The majority of research in MS has focussed on the indisputably
important role of adaptive immunity in the disease. However, it
has recently been posited that, at least in some cases, the primary
insult could be directed at the oligodendrocyte. In a seminal study
in 2004, Barnett and Prineas examined newly-forming lesions
from MS patients and found that prior to the onset of extensive
demyelination, and in the absence of T-cell infiltration, oligoden-
drocyte death could be detected, generally in association with
increased numbers of microglia [1]. This work suggests that
oligodendrocyte apoptosis and the innate immune response could
have important roles to play in the initial development of an MS
lesion. A family of receptor protein tyrosine kinases known as the
TAMs, comprised of three closely related proteins (Tyro3, Axl and
Mertk), has been shown to be centrally important in the regulation
of both oligodendrocyte survival and microglial activation.
The three TAM receptors were identified as a distinct receptor
PTK subfamily in 1991 [2]. The extracellular, ligand-binding
regions of these receptors each have a defining arrangement of two
tandem immunoglobulin-related domains and two fibronectin
type III repeats. These domains are followed by a single-pass
transmembrane domain, and a catalytically competent, cytoplas-
mic PTK [3,4,5]. Like all other receptor PTKs, the TAMs signal
as dimers. They are activated by the binding of two closely-related
ligands, Gas6 (Growth Arrest Specific Gene 6) and Protein S
(ProS), which also dimerize (reviewed in [6]).
We, and others, have recently shown that TAM signalling can
regulate myelination, microglial activation and phagocytosis
during both demyelination and remyelination in the CNS. We
showed that Gas6 knockout (KO) mice subjected to cuprizone-
induced demyelination for three weeks exhibited significant
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comparison with wild-type (WT) mice: in the absence of Gas6,
oligodendrocyte survival was compromised, demyelination was
worse and there were fewer myelinated axons [7]. In contrast, a
study by Hoehn et al. of cuprizone challenge to Axl KO mice did
not observe an increased loss of oligodendrocytes in comparison
with wild-type mice after 6 weeks of cuprizone-challenge [8]. This
apparent disparity between the relative effect of Gas6 and Axl
deficiency upon oligodendrocyte survival in mice challenged with
cuprizone suggests that a loss of signalling through a single
receptor (Axl) has a less profound effect than a reduction in
signalling through all three receptors, such as in the absence of the
ligand Gas6. Alternatively, it could be that either Tyro3 or Mer is
the main TAM receptor responsible for transducing the anti-
apoptotic effect of Gas6 in this context.
In addition to the studies in animal models of demyelination
described above, recent evidence has shown that that TAM
receptor signalling is involved in both the etiology and pathogen-
esis of MS. We recently conducted an association study to identify
single nucleotide polymorphisms (SNPs) within genes encoding the
TAM receptors and their ligands associated with MS. We
identified polymorphisms within the MERTK gene associated with
the risk of developing MS [9]. Further evidence linking TAM
signalling to the pathogenesis of MS also has emerged from studies
of human MS lesions, revealing that soluble Axl and Mer proteins,
which act as decoy receptors to sequester Gas6, are upregulated in
chronic MS lesions, and are negatively correlated with expression
of Gas6 [10]. These data suggest that a reduction in protective
Gas6 signalling could correlate with extended lesion activity.
Given the known role that Gas6 and the TAM receptors play in
regulating myelination, we examined the role of these molecules
during recovery from cuprizone-induced demyelination, and in an
in vitro model of myelination. Here, we demonstrate that the
absence of Gas6 delays, but does not ultimately prevent,
remyelination following cuprizone-induced demyelination, and
that this delay is correlated with a reduction in oligodendrocyte
numbers. This effect may be contributed to by a direct effect of
Gas6 upon myelination by oligodendrocytes, as we also show that
exogenous Gas6 can enhance myelination of dorsal root ganglion
(DRG) neurons in vitro.
Materials and Methods
Animals and reagents
Gas6
2/2 mice [11] were backcrossed onto the C57Bl6
background as previously described [7]. Sprague-Dawley rats for
primary cell culture were obtained from the Animal Resource
Centre (Canning Vale, WA, Australia).
All chemical reagents were obtained from Sigma-Aldrich (St
Louis, MO) unless otherwise indicated. Recombinant human Gas6
(rhGas6) was a kind gift of Dr Patrick Jones (Berlex Biosciences,
Richmond, CA). All cell culture plasticware was purchased from
Nunc (Rochester, NY). All cell culture media and reagents were
purchased from Invitrogen (Carlsbad, CA) unless otherwise
indicated. All secondary antibodies were purchased from Jackson
Immunochemicals (West Grove, PA) unless otherwise indicated.
Ethics Statement
All animal experiments were approved by the Florey Neurosci-
ence Institutes Animal Ethics Committee (Approval #07-063) and
conducted according to National Health and Medical Research
Council (NH&MRC) guidelines, with all appropriate effort made
to minimise animal suffering.
Purification and culture of rat oligodendrocyte precursor
cells (OPCs)
Oligodendrocyte precursor cells were purified from the cortices
of P7 Sprague-Dawley rat pups using sequential immunopanning
as previously described [12]. Purified cells were cultured in 75 cm
2
tissue culture flasks coated with poly-D-lysine (PDL) in modified
Bottenstein-SATO medium [13] containing N-acetyl-cysteine
(60 mg/ml), forskolin (5 mM), penicillin and streptomycin, neuro-
trophin-3 (NT-3, 5 ng/ml, Peprotech, Rocky Hill, NJ) and
platelet-derived growth factor-AA (PDGF-AA, 10 ng/ml, Pepro-
tech, Rocky Hill, NJ).
Co-culture of rat dorsal root ganglia (DRG) and OPCs
Rat DRG-OPC co-cultures were established based on previ-
ously described protocols [14,15]. Briefly, rat DRG neurons were
purified with antimitotic medium in the presence of NGF (100
ng/ml) for 2–3 weeks as described previously [16]. OPCs were
seeded onto coverslips containing purified DRG in a small volume
at a density of 200,000 OPCs per 22 mm coverslip or 100,000
OPC per well of 4-well chamber slides and incubated overnight to
facilitate attachment. DRG-OPC co-cultures were maintained for
14 days in a defined co-culture media containing 50:50
DMEM:Neurobasal medium with Sato and B27 supplements,
N-acetyl cysteine and D-biotin with or without Gas6 according to
the experimental paradigm.
Analysis of myelination in DRG-OPC co-culture
For analysis of protein levels using western blot, the lysates of
DRG-OPCs co-cultures were separated on an SDS-PAGE gel and
transferred to a PVDF membrane, as described previously [16].
Membranes were probed with specific antibodies against myelin
proteins (29,39-cyclic nucleotide 39-phosphodiesterase [CNPase,
Chemicon, Temecula, CA], myelin associated glycoprotein
[MAG, Chemicon, Temecula, CA] and myelin basic protein
[MBP, Chemicon, Temecula, CA]), then incubated with HRP-
conjugated secondary antibodies (Cell Signalling, Danvers, MA).
Anti-b-actin antibody (Sigma, St. Louis, CA) was used as a loading
control. Blots shown are representative of 3 independent
experiments.
For determination of the number of MBP segments, immuno-
cytochemical analysis of myelinating co-cultures was undertaken,
as described previously [16]. Briefly, the co-cultures were fixed
with 4% paraformaldehyde, then blocked with 20% calf serum in
0.2% Triton X-100 in PBS. Myelin segments were visualized with
an anti-MBP antibody (AB980, Chemicon, Temecula, CA),
followed by incubation with secondary antibodies, and images
were captured by Zeiss confocal microscopy (Carl Zeiss, Inc.
Thornwood, NY, USA). For quantitative analysis, 4 random
fluorescent images were taken as above, and the number of MBP
positive myelin segments in each field was counted.
Determination of cell death
Co-cultures of OPCs and DRG were established, as described
above. Cells were cultured for either 1, 2, 7 or 14 days with
appropriate factors depending on the experimental paradigm.
Ethidium homodimer-1 (4 mM) and calcein AM (4 mM) were
added to each well. Cells were then visualised on an inverted
fluorescent microscope (Zeiss, Thornwood, NY) and live (calcein
AM positive) and dead (ethidium homodimer-1 positive) cells
counted. For all assays 3 wells were counted per condition and
assays were repeated at least two times with independent cell
isolations. All results are expressed as % live cells6SEM.
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Cuprizone mediated demyelination was induced by feeding 8–10
week old mice powdered feed (Barastoc, Pakenham, Victoria,
Australia) containing 0.2% cuprizone (w/w: bis-cyclohexanone-
oxaldihydrazone) for 5 weeks. Mice were then returned to a normal
diet for either 0, 2, 4 or 10 weeks, according to the experimental
paradigm. During the 5 week demyelination phase, feed was
refreshed each day. Wild-type littermates were used as controls for
induction of demyelination in Gas6
2/2 cohorts. In one cohort
(cohort 3), the wild-type, control animals were supplemented with
separately bred C57Bl6 mice to increase available numbers. For
eachcohortanequal mix of male and femaleGas6
+/+ and Gas6
2/2
mice were subjected to cuprizone challenge. Consistent with
previous findings [17], no gender effect was identified. The brains
of animals from cohorts 1 and 2 were embedded, cut and analysed
in sagittal orientation, whereas those from cohort 3 were embedded,
cut and analysed in the coronal orientation.
Histology
Mice were anaesthetised and perfused intracardially with PBS
followed by 4% paraformaldehyde and the brains embedded in
paraffin or, for cryosectioning, were equilibrated successively in
12%, 16% and 18% sucrose in PBS for cryoprotection and then
frozen on dry ice. Cryostat sections of 15 mm were collected onto
chrom-alum coated slides. For coronal analysis, frozen sections
were selected from appropriate regions of the brain: rostral
sections were as close to Bregma 0.38 as the series of sections
would allow; middle from Bregma 20.70; caudal from Bregma
20.94 [18]. Sagittal paraffin sections (10 mm) were selected as
close to lateral 0.12 mm as the series of sections would allow [18].
Myelination in cuprizone challenged animals was assessed using
luxol fast blue (LFB)-periodic acid Schiff (PAS) reagent using
paraffin embedded sections.
For electron microscopic evaluation of myelin, mice were perfused
as above and processed for resin embedding. Semi-thin sections
(0.5 mm) were cut to evaluate quality and orientation. Representative
samples were then chosen and ultra-thin sections (90 nm) cut and
images captured using a Siemens Stereoskop Transmission Electron
Microscope (Siemens, Munich, Germany) at 30006.S e c t i o n s
corresponding to the aforementioned Bregma locations were imaged
and a region of interest (ROI) randomly selected for quantification by
an observer blind to genotype and treatment.
Quantification and morphometric analysis of axon
myelination
Images of the appropriate ROI were imported into Image J64
(US National Institutes of Health, Bethesda). The threshold
function of Image J64 was used to outline the myelin within each
image, with threshold levels adjusted manually. The number of
myelinated axons within each ROI was counted manually. The
measure function was used to determine both the internal area of
each myelinated axon and the area of the whole axon including
myelin wrappings. The diameter of each axon and total fibre
diameter was calculated mathematically from the internal area or
the whole axon area respectively, as the diameter of a circle of
equivalent area [19]. The g-ratio for each axon was calculated as a
ratio of axon diameter/fibre diameter. Counts of myelinated
axons, axon diameter and g-ratios are expressed as mean6 SEM.
Quantification of oligodendrocyte and microglia number
Sections of frozen tissue were prepared as described above.
Sections were fixed in 4% paraformaldehyde. Primary antibodies
were used at 1/500 and sourced as follows: anti-Olig2 (Millipore,
Billerica, MA); anti-IBA1 (Wako Chemicals, Richmond, VA); anti-
GFAP (Dako, Carpinteria, CA); anti-PDGFRa (Fitzgerald, Con-
cord, MA); anti-APC(CC1) (EMD Chemicals, Gibbstown. NJ).
Appropriate secondary antibodies were used at 1/500 and the final
antibody incubation included Hoescht 33342 (1/2000, Invitrogen)
to visualise the nuclei of all cells. For cell counts, images were
captured from 3 sections for each individual animal using a Carl
Zeiss Axioplan microscope at 206 objective. All immunopositive
cells in the corpus callosum contained within the imaged region
were counted, and the area of the corpus callosum measured using
NIHImageJ64(USNational Institutesof Health,Bethesda). Counts
are expressed as number of positive cells/mm
26 SEM.
Quantification of LFB
Image analysis of LFB stained sections was performed according
to procedures previously described [20]. Briefly, all images from a
given experiment were acquired in a single session using the same
light intensity and filter settings with the white balance of all
images standardised. Images were captured using a Carl Zeiss
Axioplan microscope with a 56 objective. For quantification of
LFB density, images were divided into equal thirds corresponding
to rostral, middle and caudal segments. The area of the corpus
callosum was determined using the NIH ImageJ64 (US National
Institutes of Health, Bethesda). Density measurements are
expressed as raw mean intensity6SEM.
Statistical analysis
All statistical analysis was performed using GraphPad Prism 5
software (GraphPad Software Inc., La Jolla). Differences between
genotypes were compared using Students t-tests. Single-factor,
multiple condition experiments were analysed using one-way
ANOVA with Bonferroni’s post-hoc tests. A p-value of less than
0.05 was considered to be statistically significant.
Results
Early remyelination is influenced by the absence of Gas6
We initially investigated whether the absence of Gas6 affects the
rate or level of remyelination following cuprizone-induced demy-
elination. Given our previous results showing that demyelination is
greater in the absence of Gas6 following 3 weeks of cuprizone
challenge [7], we chose a 5 week time-point of cuprizone challenge
to provide nadir levels of demyelination in both Gas6
+/+ and
Gas6
2/2 mice. After 5 weeks of cuprizone challenge, mice were
returned to a normal (cuprizone-free) diet for either 0, 2 or 4 weeks.
To analyse the extent of remyelination in wild-type and Gas6
knockout mice, the corpus callosum was segmented lengthwise into
3 equal segments as previously described [7]: rostral, middle and
caudal (outlined in Fig. 1A), and the level of myelination assessed
using LFB staining as described in the Materials and Methods.
RepresentativeimagesofallgroupsareshowninFigure1(A–F).We
detected an effect of the loss of Gas6 in the rostral and middle
segments, with Gas6
2/2 mice showing lower myelin density than
wild-type mice after 4 weeks of recovery following 5 weeks of
cuprizone-challenge,althoughinthemiddle segment thiswas onlya
trend (rostral p=0.039, Fig. 1G; middle p=0.052, Fig. 1H).
To clarify the changes in remyelination detected using LFB
analysis, we next performed an ultrastructural analysis of all
segments using electron microscopy. The number of myelinated
axons was determined for both Gas6
+/+ and Gas6
2/2 mice, as well
as the diameter of each myelinated axon and the thickness of the
myelin surrounding each axon. Representative images of each
group are shown in Figure 2 (A–F). In agreement with the LFB
analysis, we detected an effect of the loss of Gas6, with Gas6
2/2
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4 weeks of recovery. However, in contrast to the LFB analysis this
only reached significance in the caudal segment (Fig. 2I; p=0.032).
In addition to determining the number of myelinated axons in
each segment, each myelinated axon was assessed for diameter
and myelin thickness (expressed as g-ratio) as described in the
Material and Methods, with the data shown in Table 1. No
differences between wild-type and Gas6
2/2 mice were observed in
any of the measures, except for a significant increase following 5
weeks of cuprizone challenge in the mean diameter of myelinated
axons (Table 1, p=0.009) and a decrease in the thickness of
myelin surrounding the axons in the rostral segment of the corpus
callosum of Gas6
2/2 mice (Table 1, p=0.007).
Taken together, the analysis of myelination in the absence of
Gas6indicates a significant effecton the remyelinationprocess, with
an apparently lower level of myelination after 4 weeks of recovery
following 5 weeks of cuprizone challenge, with the maximum effect
observed in any parameter being a reduction of approximately 43%
in the number of myelinated axons in the caudal segment following
4 weeks of recovery (4.68610
5 vs 2.70610
5 axons/mm
2 in Gas6
+/+
vs Gas6
2/2 mice respectively; Fig. 2I).
The absence of Gas6 delays but does not prevent
recovery of myelination
Given the data showing a decrease in myelination following 4
weeks of recovery, we next examined whether this decrease was
chronic or if myelin levels recovered to wild-type levels over time.
To test this, an independent cohort of mice was subjected to
cuprizone challenge for 5 weeks, and then returned to a
cuprizone-free diet for either 0 or 10 weeks. As for the previous
Figure 1. LFB staining demonstrates a reduction in the extent of remyelination in the absence of Gas6. A–F Wild-type and Gas6 KO
mice were subjected to cuprizone challenge for 5 weeks followed by recovery in the absence of cuprizone for 0, 2 or 4 weeks. A. The corpus callosum
was divided into three segments for image analysis: rostral (R), Middle (M) and Caudal (C) G–I Myelin density was assessed using image analysis as
described in the Materials and Methods. G. A significant reduction in myelination was observed in the rostral segment of the corpus callosum
(p=0.039) and a strong trend towards reduction was observed in the middle segment (p=0.052) (H). Scale bar=1 mm.
doi:10.1371/journal.pone.0017727.g001
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microscopy and the number of myelinated axons per mm
2
quantified. Representative images of each group are shown in
Figure 3 (A–L). In contrast to the shorter time-points of recovery,
after 10 weeks of recovery following 5 weeks of cuprizone
challenge, no significant difference in the number of myelinated
axons/mm
2 was observed between Gas6
2/2 and wild-type mice
in any segment.
Figure 2. EM analysis demonstrates a reduction in the number of myelinated axons during the course of remyelination in the
absence of Gas6. A–F Wild-type and Gas6 KO mice were subjected to cuprizone challenge for 5 weeks followed by recovery in the absence of
cuprizone for 0, 2 or 4 weeks. The number of myelinated axons per mm
2 was quantified and shown in G–I. A significant reduction in myelination was
observed in the caudal (I) segments of the corpus callosum in Gas6
2/2 mice compared with Gas6
+/+ mice (p=0.032). Scale bar=2 mm.
doi:10.1371/journal.pone.0017727.g002
Table 1. Axon Diameter and g-ratios in Gas6
+/+ and Gas6
2/2 mice during remyelination.
Weeks
Recovery Genotype Axon diameter (mm
2) g-ratio
Rostral Middle Caudal Rostral Middle Caudal
0 Gas6
+/+ 0.60460.020 0.78160.163 0.60160.041 0.68860.005 0.70360.033 0.68860.014
Gas6
2/2 0.71860.018* 0.64560.035 0.59760.060 0.74660.010* 0.68460.005 0.64860.026
2 Gas6
+/+ 0.70460.039 0.63760.037 0.58860.028 0.71160.010 0.67860.014 0.65160.023
Gas6
2/2 0.68360.018 0.65760.064 0.57160.062 0.68660.008 0.71560.025 0.67260.017
4 Gas6
+/+ 0.66560.046 0.62660.038 0.58560.011 0.70460.019 0.67760.009 0.66260.013
Gas6
2/2 0.72260.056 0.59860.027 0.57960.015 0.70560.023 0.68960.012 0.66060.002
*p,0.05.
doi:10.1371/journal.pone.0017727.t001
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and myelin thickness (Table 2). No difference in either the
diameter of myelinated axons or in the thickness of myelin
surrounding axons was observed between Gas6
+/+ and Gas6
2/2
mice following 10 weeks of remyelination. However, as detected in
the previous cohort, small differences were once again observed
following 5 weeks of cuprizone challenge, with Gas62/2 mice
showing a significant increase in the mean diameter of myelinated
axons in the caudal segment (Table 2, p=0.019), and significantly
thinner myelin in the middle segment (Table 2, p=0.034).
Taken together, these data indicate that, in contrast to the findings
after 4 weeks of recovery following 5 weeks of cuprizone challenge,
there is no difference in either the number or size of myelinated
axons, or in the thickness of myelin, following 10 weeks recovery.
Expression of oligodendrocyte markers is reduced
following 4 weeks of remyelination
We next examined whether the delay in the myelination
observed in the absence of Gas6 correlated with a reduction in
oligodendrocyte numbers. A separate cohort of mice was
challenged with cuprizone for 5 weeks and then returned to a
cuprizone-free diet for 0, 2, 4 or 10 weeks. Coronal sections were
collected as described in the Materials and Methods then stained
with anti-APC(CC1) to determine the number of mature
oligodendrocytes, with adjacent sections double-stained with
anti-Olig2 and anti-PDGFRa to determine the number of
oligodendrocyte precursors. The number of positive cells in all 3
segments - rostral, middle and caudal - was determined.
Representative images from the middle segment at each time-
point are shown in Figure 4(A). We observed a reduction in the
number of mature oligodendrocytes in the absence of Gas6
following cuprizone challenge, as measured by expression of
APC(CC1), with the caudal segment showing a significant loss of
APC(CC1) oligodendrocytes following 4 weeks of remyelination
(Fig. 4D, 1331+/274 cells/mm2 vs 717+/2129 cells/mm
2,
Gas6
+/+ vs Gas6
2/2 mice respectively, p=0.007). Additionally,
the middle segment showed a trend towards a reduction in the
number of APC(CC1) positive oligodendrocytes following 4 weeks
of remyelination (Fig. 4C, p=0.067). Furthermore, a strong trend
towards a reduction in the number of APC(CC1) positive
Figure 3. EM analysis demonstrates that, following 10 weeks of recovery, Gas6 KO mice remyelinate to the same extent as Gas6 WT
mice. A–L Wild-type and Gas6 KO mice were subjected to cuprizone challenge for 5 weeks followed by recovery in the absence of cuprizone for 0 or
10 weeks. The number of myelinated axons/mm
2 was quantified in the rostral, middle and caudal segments of the corpus callosum (M–O). No
significant differences were observed between Gas6
2/2 or Gas6
+/+ mice at any time point or in segment (p.0.05). Scale bar=2 mm.
doi:10.1371/journal.pone.0017727.g003
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+/+ and Gas6
2/2 mice during long-term remyelination.
Weeks
Recovery Genotype Axon diameter (mm
2) g-ratio
Rostral Middle Caudal Rostral Middle Caudal
0 Gas6
+/+ 0.65660.030 0.68860.050 0.51160.032 0.69360.017 0.71160.009 0.68760.021
Gas6
2/2 0.58860.049 0.76460.129 0.66260.039* 0.68060.012 0.76260.020* 0.68660.009
10 Gas6
+/+ 0.64260.018 0.62560.022 0.50460.031 0.69960.008 0.68260.011 0.65360.029
Gas6
2/2 0.65260.016 0.59560.027 0.57160.044 0.70660.010 0.66960.011 0.65960.014
*p,0.05.
doi:10.1371/journal.pone.0017727.t002
Figure 4. Expression of oligodendrocyte lineage markers are altered in the absence of Gas6 during remyelination. Wild-type and Gas6
KO mice were subjected to cuprizone challenge for 5 weeks followed by recovery in the absence of cuprizone for 0, 2, 4 or 10 weeks. A.
Representative images of the middle segment of the corpus callosum, showing cells positive for APC(CC1) or double positive for Olig2/PDGFRa. B–G.
A significant reduction in the number of APC(CC1) positive cells was observed in the caudal segment of the corpus callosum in Gas6
2/2 mice
compared with Gas6
+/+ mice (p=0.0070) (D). The density of Olig2+/PDGFRa+ OPCs was significantly increased in Gas6
2/2 mice compared with
Gas6
+/+ mice following both 4 and 10 weeks of remyelination (4 weeks, p=0.024; 10 weeks, p=0.003) (E). Scale bar=20 mm.
doi:10.1371/journal.pone.0017727.g004
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weeks of recovery (Fig. 4D, p=0.052).
Taken together, these data indicate that the delay in myelination
observed in the absence of Gas6 parallels a reduction in the number
of APC(CC1) immunopositive oligodendrocytes. In particular, the
only segment to show a significant reduction in APC(CC1) positive
oligodendrocytes, the caudal segment following 4 weeks remyelina-
tion, was also the sole segment that displayed a significant reduction
in the number of myelinated axons at the same time-point.
To assess whether numbers of OPCs were also affected by Gas6
deficiency, the density of PDGFRa/Olig2 double immunopositive
cells was determined. The middle and caudal segments showed no
apparent differences in OPC numbers at any time-point
(Fig. 4H,I). In contrast, the rostral segment of the corpus callosum
showed a significant effect, with more OPCs observed in the
absence of Gas6 following both 4 weeks of remyelination (Fig. 4E,
p=0.025) and 10 weeks of remyelination (Fig. 4E, p=0.003).
Reduction in oligodendrocyte markers is not correlated
with an increase in numbers of microglia in the absence
of Gas6
We next wished to determine if the reduction of oligodendro-
cyte markers in the absence of Gas6 was correlated with an
increase in the number of microglia. We therefore assessed the
number of IBA1 positive microglia in mice after 5 weeks of
cuprizone challenge and following 0, 2, 4 or 10 weeks recovery in
the absence of cuprizone. The number of IBA1 positive cells was
determined in both Gas6
2/2 and Gas6
+/+ mice in all three
segments of the corpus callosum - rostral, middle and caudal.
Representative images of the middle segment are shown in
figure 5A. No significant differences were observed between
Gas6
2/2 and Gas6
+/+ mice at any time-point examined, with the
exception that an increase in the number of IBA1 positive
microglia was seen in the middle segment following 10 weeks of
remyelination (Fig. 5C, p=0.013). However, as no difference was
observed in the number of APC(CC1) positive oligodendrocytes at
this time in this segment, these data indicate that the increased loss
of oligodendrocyte markers observed in the absence of Gas6
2/2 is
not directly linked to an increase in the number of microglia.
Exogenous Gas6 can directly increase myelination of
neurons in vitro
We additionally wished to assess if, in addition to affecting
numbers of oligodendrocytes, Gas6 could also directly affect the
capacity of oligodendrocytes to myelinate axons. In order to assess
this, we employed an in vitro system, co-culturing OPCs with
retinal ganglion cells in the presence or absence of exogenous
rhGas6, as described in the Materials and Methods. Upon
addition of rhGas6, a dose-dependent significant increase in the
number of myelin basic protein (MBP)-positive segments was
observed (Figure 6 A–E, p,0.0001). This increase in MBP-
positive segments paralleled an increase in the expression of
myelin components as determined using Western analysis for
CNPase, myelin associated glycoprotein (MAG) and MBP. This
increase in myelination did not appear to be a result of improved
viability of OPCs in this assay, as no improvement in survival of
cells could be detected at 2, 7 or 14 days in the presence of
exogenous Gas6 (data not shown). These data indicate that
exogenous Gas6 can directly increase the number of myelinated
axons in an in vitro culture system, suggesting that the delay
observed in recovery from cuprizone-challenge in the absence of
Gas6 may be partially a result of a deficit in myelination, rather
than simply reflecting a loss of oligodendrocytes.
Discussion
In this study we show that the absence of Gas6 affects the
efficiency of remyelination following a demyelinating insult,
induced by cuprizone, such that remyelination is delayed,
although not ultimately prevented. This delay in remyelination is
paralleled by a significant decrease in the number of mature
oligodendrocytes. This decrease in oligodendrocytes was specifi-
cally observed in the caudal corpus callosum during remyelination,
the segment of the corpus callosum most affected by cuprizone.
Interestingly, this reduction in oligodendrocyte markers is not
correlated with an increase in the number of microglia in the
absence of Gas6, suggesting a direct effect of the absence of Gas6
on oligodendrocytes in the remyelination phase. In support of this,
we show that exogenous Gas6 can directly enhance the
myelination of DRG neurons in vitro by oligodendrocytes.
Collectively, these data indicate that Gas6 and TAM receptor
signalling plays an important role in the process of remyelination
following a demyelinating insult, and that this effect could be
transduced, at least in part, via a direct effect of Gas6 on
myelination by oligodendrocytes.
In demyelinating diseases such as MS, whilst remyelination
occurs, it is often inadequate or eventually fails. This failure is
thought to result from a variety of factors, including a deficiency of
OPCs, or the failure of these OPCs to reach the correct target, or
alternatively, failure of differentiation of OPCs resident within
lesions (reviewed in [21]). In this study, we show that in the
absence of Gas6 there is a significant delay in the remyelination
process following cuprizone-induced demyelination. Although
remyelination is not ultimately prevented, the decrease in the
efficiency of remyelination observed in the absence of Gas6 could
lead to an increase in the vulnerability of axons [22,23]. As the loss
of axons has been shown to be closely related to disability in MS
(reviewed in [24]), the apparent role of Gas6 in increasing the
efficiency of remyelination could be an important factor in
preventing or reducing axon loss.
What mediates this delay in remyelination? As indicated above,
a number of factors has been postulated to be important in
ensuring the efficiency of remyelination, not least of which is the
number and localisation of OPCs. In this study, we have shown
that whilst there were some changes in the number of PDGFRa/
Olig2 positive OPCs in mice in the absence of Gas6 compared
with WT mice, specifically in the rostral segment of the corpus
callosum, these changes did not clearly correlate with the changes
observed in remyelination efficiency. This suggests that the effect
of the loss of Gas6 upon remyelination is not upon either the
number or recruitment of OPCs to the damaged region. This
further suggests that the loss of Gas6 has a direct effect upon either
extant or new mature oligodendrocytes during remyelination.
Our examination of mature oligodendrocytes showed that the
reduction in myelination observed following 4 weeks of recovery
paralleled a significant reduction in the expression of the
oligodendrocyte marker APC(CC1). It is not possible to determine
from these data whether the loss of marker expression indicates an
increase in the death of mature oligodendrocytes or an increase in
dysfunction following initial recovery. We and others have
previously shown that Gas6 is an important anti-apoptotic signal
for oligodendrocytes [7,25,26], and it is possible that a reduction in
survival signals could lead to the observed effects. However, recent
work from Hesse et al. [27] indicates that the vast majority of
oligodendrocytes undergo apoptosis during the first 3 weeks of
cuprizone challenge. Given that differences in the number of
mature oligodendrocyte markers between Gas6
2/2 and Gas6
+/+
were not observed until 4 weeks post-cuprizone challenge, and that
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positive oligodendrocytes was equal between both genotypes, it
seems unlikely that the differences observed are the result of cell
death, but are more likely to result from either a dysregulation in
the expression of these markers and/or in the maturation of these
cells.
The mature oligodendrocyte marker APC(CC1) is an antagonist
of b-catenin and results in a reduction in Wnt signalling [28]. It
has previously been shown by Fancy et al. (2009) that whilst Wnt-b-
catenin signalling is upregulated during normal developmental
myelination and during remyelination, the timely inhibition of the
Wnt-b-catenin signalling pathway is required or remyelination is
blocked [29]. We observed a significant reduction in APC(CC1)
expression in the caudal segment of the corpus callosum and a
strong trend for a reduction in APC expression in the middle
segment of the corpus callosum after 4 weeks of recovery following
cuprizone challenge, the time at which we observed a reduction in
myelin density and a reduction in myelinated axons in the absence
of Gas6. These findings suggest the intriguing hypothesis that
dysregulation in the Wnt-b-catenin signalling pathway could be
responsible for the reduced efficiency of remyelination observed in
the absence of Gas6, a possibility that merits specific interrogation
in future experiments.
It is also possible that the observed effects on remyelination
could result from other effects of the absence of Gas6 on
myelination. These effects could be either direct or indirect. We
have previously shown that during demyelination in the absence of
Gas6, there was both a loss of oligodendrocytes and a concomitant
Figure 5. The number of IBA1 positive microglia is minimally altered by the absence of Gas6 during remyelination. Wild-type and
Gas6 KO mice were subjected to cuprizone challenge for 5 weeks followed by recovery in the absence of cuprizone for 0, 2, 4 or 10 weeks. A.
Representative images of the middle segment of the corpus callosum, showing cells positive for IBA1. B–D The number of IBA1 positive cells/mm2
was quantified. A significant increase in the number of IBA1-positive microglia was observed in Gas6
2/2 mice compared with Gas6
+/+ mice following
10 weeks of remyelination (p=0.031). Scale bar=20 mm.
doi:10.1371/journal.pone.0017727.g005
Remyelination Is Inhibited by Loss of Gas6
PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17727increase in the number of IBA1-positive oligodendrocytes in the
corpus callosum following 3 weeks of cuprizone challenge [7].
However, it was not clear whether the increase in oligodendrocyte
loss was a primary effect of the absence of Gas6, or whether it was
secondary to the increase in microglial numbers. Hoehn et al.
(2008) examined a number of time-points in WT and Axl KO
cuprizone-mediated demyelination and, in contrast to the findings
in Gas6 KO mice, observed a significant decrease in microglia in
Axl KO mice after 4 weeks of cuprizone challenge. There was also
a delay in phagocytosis and in the removal of myelin debris in
these mice [8]. Here we show that the reduction in mature
oligodendrocyte markers in Gas6
2/2 mice occurs in the absence
of a differential increase in numbers of IBA1 positive microglia,
suggesting a direct effect of the absence of Gas6 on mature
oligodendrocytes. Our in vitro data showing that exogenous Gas6
can increase the myelination of DRG neurons by OPCs is also
strongly suggestive of a direct effect of Gas6 on myelination by
oligodendrocytes following a demyelinating challenge. The
apparent disparity in the results between the Axl
2/2 mice and
the Gas6
2/2 mice could reflect the ability of alternate members of
Figure 6. Exogenous Gas6 increases the number of myelinated DRG neurons when co-cultured with oligodendrocytes. A–D
Oligodendrocytes and DRG neurons were co-cultured as described in the Materials and Methods. Exogenous Gas6 was added to the cultures at either
0 ng/ml (A), 1 ng/ml (B), 10 ng/ml (C) or 100 ng/ml (D) and the number of myelinated segments quantified, with the results shown in (E). Exogenous
Gas6 significantly increased the number of myelinated segments in a dose-dependant manner (p,0.0001). F Western analysis showing exogenous
Gas6 increased the expression of myelin compenents. Scale bar=100 mm.
doi:10.1371/journal.pone.0017727.g006
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whereas the overall reduction in signalling that accompanies the
loss of an important ligand could outstrip the ability of, for
example, ProS to compensate for this loss.
The results presented in this study indicate an important role for
Gas6 and TAM receptor signalling during remyelination, in
addition to the known role of this signalling pathway during
demyelination. In the absence of Gas6, remyelination is slowed,
potentially increasing the length of time to which axons are
exposed to damage. Additional work is required to determine the
mechanisms by which remyelination efficiency is reduced in the
absence of Gas6, in particular whether Gas6 can directly increase
myelination by oligodendrocytes in vivo as well as in vitro.
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